Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Advertising Strategy Relies On “Guerrilla” Tactics – CEO Guerry

This article was originally published in The Tan Sheet

Executive Summary

Chattem's advertising strategy focuses on acquiring media time "as a guerilla buyer as opposed to a big buyer," CEO Zan Guerry maintained at a Banc of America Securities consumer conference in New York April 10

Chattem's advertising strategy focuses on acquiring media time "as a guerilla buyer as opposed to a big buyer," CEO Zan Guerry maintained at a Banc of America Securities consumer conference in New York April 10.

"Hemingway was the greatest role model because he was short and succinct," Guerry said, noting a similar approach in the advertising for Chattem's consumer products has proven effective.

"One of the things that has really propelled our growth is that now there are a lot of 15- and 10-second spots available [on TV]," he said. "That triples your efficiency if you can get your message across."

As an example, Guerry pointed to the ad campaign for Chattem's Garlique dietary supplements. Since the company began running 10-second spots "on some shows [where] we really could not afford" to buy longer periods of ad time, the garlic supplement's sales have risen over 40%, he said.

Garlique's fiscal first quarter sales jumped 29% over the year-ago period (1 (Also see "Chattem pHisoderm Clear Swab Launch Will Target “Back-To-School” Crowd" - Pink Sheet, 1 Apr, 2002.), p. 10).

When asked his opinion on promotions, Guerry replied, "If we had our sales force in here they would call me 'the hater of promotional spending.'"

"We fight very hard to keep special events spending as low as possible...we are doing stuff every year to make it less and to make it more efficient," he continued.

Guerry said one of the reasons Chattem divested the Ban antiperspirant line several years ago was because the company felt it had to invest too much in promotional spending to be successful in the category, and "we do not want to play that game."

Chattem's ads for the recently acquired Selsun Blue dandruff shampoo brand will stress the product's ability to give consumers better looking hair, not just relieve them of dandruff, Guerry said. TV ads are slated to launch in June; Chattem acquired the line from Abbott Labs in March (2 (Also see "Chattem Selsun Blue Purchase Provides Entry Into Five New Foreign Markets" - Pink Sheet, 11 Mar, 2002.), p. 5).

"We think we can add 30% to 50%" to Selsun Blue's revenues "just on more advertising and focusing the ad attack," Guerry said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093873

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel